Purdue Pharma

Ohio Attorney General Dave Yost has agreed to a settlement with McKinsey & Co. that will pour more than $24 million into communities to help combat the devastating effects of an opioid epidemic that has ripped apart communities and families throughout the state.

What You Need To Know: - Family behind Purdue Pharma testified before Congress on Thursday - Ohio lawmakers are pushing to refocus attention on worsening opioid crisis - OSU addiction specialist says pandemic “definitely” led to resurgence of opioid epidemic

The company, which produced OxyContin, faces penalties of $8.3 billion. But families of those addicted are skeptical of the tangible benefits.

BRUNSWICK, Ohio -- The Brunswick Board of Education on Monday (Aug. 17) authorized the school district’s participation in a bankruptcy filing by Purdue Pharma, makers of the opioid drug OxyContin.

Billions from the Purdue Pharma bankruptcy could fund wider use of opioid overdose treatments, programs for babies born addicted, and support programs for mothers and people in jail, according to a draft proposal obtained by Bloomberg Law.

New details emerge in a lawsuit asserting that chains including CVS, Rite Aid and Walgreens sold millions of pills in small towns but rarely flagged suspicious orders to authorities.

State and local governments have been leading the legal fight against the opioid industry, seeking payouts to help them deal with the fallout from the nation’s addiction crisis. Average Americans are about to get their shot.

Companies fought to keep the videos, which are evidence in a huge, multi-state lawsuit fought in Ohio, under seal